TARDBP and Cognitive impairment: Furthermore, as many as 57% of Alzheimer’s disease (AD) patients display TDP-43 copathology, which is often described as LATE neuropathologic change (LATE-NC) (5) and correlates with more rapid disease progression and worse cognitive impairment (6, 7).